NRC Health Announces $60 Million Share Repurchase Authorization
National Research Corporation, doing business as NRC Health, has announced that its Board of Directors has approved a new stock repurchase program that allows the company to buy back up to $60 million worth of its outstanding common stock. The program is authorized to remain in effect through March 31, 2028, giving the company flexibility to execute repurchases over an extended period based on market conditions and corporate priorities.
The share repurchase authorization reflects the company’s confidence in its long-term strategy and financial position. By enabling the repurchase of common stock, NRC Health aims to return capital to shareholders while maintaining the flexibility to invest in its ongoing growth initiatives. The company’s leadership emphasized that the authorization is part of its broader approach to disciplined capital allocation, balancing shareholder returns with continued investments in innovation and customer experience solutions for healthcare organizations.
Under the program, NRC Health may buy back shares periodically using several different methods. The company indicated that purchases may occur through open market transactions, privately negotiated deals, or other means permitted under applicable securities regulations. These transactions will comply with the provisions of the Securities Exchange Act of 1934 and other relevant regulatory guidelines governing share repurchases by publicly traded companies.
One of the frameworks NRC Health may use to conduct repurchases in the open market is Rule 10b-18, which provides companies with a “safe harbor” when buying back their own shares. Rule 10b-18 establishes specific conditions related to the timing, price, volume, and manner of repurchases to help ensure that buyback activities do not manipulate or artificially influence the company’s stock price. By adhering to this rule, companies can conduct repurchases in a manner that aligns with regulatory standards and market transparency.
In addition, NRC Health may choose to establish trading plans under Rule 10b5-1. These plans allow companies to set predetermined instructions for stock repurchases, enabling transactions to occur even during periods when the company might otherwise be restricted from trading its shares due to possession of material non-public information. Rule 10b5-1 plans are widely used by public companies to facilitate structured and compliant share repurchase programs.
The company noted that the exact timing and scale of repurchases will depend on several factors. These include overall market conditions, the company’s financial performance, prevailing stock prices, and broader economic trends that may influence the value of its shares. Corporate priorities and regulatory requirements will also play an important role in determining when and how the company executes buybacks.
NRC Health emphasized that the authorization provides flexibility rather than a fixed obligation to repurchase shares. The company may decide to accelerate or slow down purchases depending on market opportunities or internal strategic considerations. Furthermore, the repurchase program can be modified, suspended, or discontinued at any time at the company’s discretion.
Share repurchase programs are a common tool used by publicly traded companies to manage their capital structure and deliver value to shareholders. By buying back outstanding shares, companies can reduce the number of shares available in the market, which may increase earnings per share and potentially support the stock’s market value over time. Buybacks can also signal management’s belief that the company’s stock is undervalued or that the organization has sufficient financial resources to return capital to investors.
For NRC Health, the repurchase authorization comes at a time when the company continues to expand its role in the healthcare experience improvement sector. The organization provides technology-driven insights, analytics, and solutions that help healthcare providers better understand patient needs and enhance care experiences. By collecting and analyzing patient feedback, the company enables hospitals and health systems to make informed decisions that improve satisfaction, engagement, and clinical outcomes.
NRC Health’s platform combines advanced analytics with real-time feedback tools to help healthcare organizations measure and improve patient experiences across the care continuum. Its solutions allow providers to capture insights from patients, families, and communities, providing valuable information that can guide service improvements, strengthen patient relationships, and enhance care quality.
Healthcare systems increasingly rely on data-driven strategies to deliver patient-centered care, and companies like NRC Health play an important role in enabling that transformation. By providing actionable insights and engagement tools, NRC Health supports healthcare organizations in addressing the evolving expectations of patients and regulatory bodies alike.
The company’s long-term strategy focuses on leveraging data analytics, digital engagement technologies, and experience management platforms to help healthcare providers deliver more personalized and responsive care. With healthcare systems facing growing pressure to improve patient outcomes while managing costs, tools that provide accurate and timely insights into patient experiences have become increasingly valuable.
NRC Health’s leadership believes that maintaining a strong financial foundation is essential to supporting innovation and delivering value to customers and shareholders. The newly announced share repurchase program is intended to complement these efforts by optimizing the company’s capital allocation strategy while continuing to fund growth initiatives.
Over the years, NRC Health has built a reputation as a trusted partner to healthcare organizations across the United States. Its solutions are widely used by hospitals, clinics, and health systems seeking to measure patient perceptions, identify service improvement opportunities, and build stronger relationships with their communities.
The company’s expertise in patient experience management has become particularly important as healthcare providers strive to improve quality metrics and meet value-based care standards. By helping organizations better understand the patient perspective, NRC Health supports efforts to enhance communication, streamline care delivery, and improve overall satisfaction.
While the newly authorized repurchase program demonstrates the company’s confidence in its financial outlook, NRC Health reiterated that the execution of the program will remain flexible. Market conditions and corporate priorities may influence the pace of repurchases, and there is no guarantee that the full $60 million authorization will be utilized.
Ultimately, the board’s approval of the repurchase program reflects NRC Health’s commitment to maintaining a balanced approach to financial management. By combining strategic investments in its healthcare experience solutions with initiatives designed to return value to shareholders, the company aims to strengthen its position in the evolving healthcare analytics landscape.
As the healthcare industry continues to shift toward more patient-centered models of care, NRC Health remains focused on helping providers deliver meaningful and measurable improvements in the patient experience. The company believes that its solutions, combined with disciplined financial strategies such as the newly announced share repurchase authorization, will support its long-term mission of improving healthcare experiences for patients and communities.
With the repurchase program now in place through March 2028, NRC Health will continue to monitor market conditions and corporate priorities to determine when and how shares may be repurchased. The authorization provides the company with a flexible mechanism to manage its capital while remaining focused on innovation, growth, and delivering value to its stakeholders.
About NRC Health
For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know the patients, families, consumers, employees, and communities they serve on a human level. Guided by its uniquely empathic heritage, human-centered approach, unmatched national market research, and emphasis on consumer preferences, NRC Health is transforming the healthcare experience, creating strong outcomes across the healthcare journey.
This press release contains certain statements that may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are subject to the safe harbor created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such statements may be identified by their use of terms or phrases such as “believes,” “expect,” “focus,” “potential,” “will,” derivations thereof, and similar terms and phrases. In this press release, the statements related to future dividends are forward-looking statements. Forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, which could cause future events and actual results to differ materially from those set forth in, contemplated by, or underlying the forward-looking statements, including those risks and uncertainties as set forth in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2025, and various disclosures in our press releases, stockholder reports, and other filings with the Securities and Exchange Commission. We disclaim any obligation to update or revise any forward-looking statements to reflect actual results or changes in the factors affecting the forward-looking information.
